Question 2: Etanercept or adalimumab: which is a better biological therapy for juvenile idiopathic arthritis? | Archives of Disease in Childhood

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via RCPCH

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Archimedes

Question 2: Etanercept or adalimumab: which is a better biological therapy for juvenile idiopathic arthritis?

Online download statistics by month:

Online download statistics by month: September 2018 to February 2023

	Abstract	Full	Pdf
Sep 2018	184	19	15
Oct 2018	659	106	55
Nov 2018	271	36	17
Dec 2018	113	13	6
Jan 2019	102	16	6
Feb 2019	82	11	2
Mar 2019	104	9	5
Apr 2019	75	5	1
May 2019	72	8	9
Jun 2019	72	2	4
Jul 2019	58	4	4
Aug 2019	29	2	1
Sep 2019	45	3	2
Oct 2019	32	0	2
Nov 2019	29	3	2
Dec 2019	22	0	0
Jan 2020	29	2	1
Feb 2020	48	4	1
Mar 2020	34	0	0
Apr 2020	28	3	2
May 2020	33	0	0
Jun 2020	23	0	1
Jul 2020	18	0	0
Aug 2020	8	0	0
Sep 2020	75	1	0
Oct 2020	66	1	1
Nov 2020	26	0	0
Dec 2020	29	0	0
Jan 2021	21	0	0
Feb 2021	23	0	0
Mar 2021	16	0	1
Apr 2021	14	0	0
May 2021	4	2	1
Jul 2021	1	1	0
Aug 2021	2	0	0
Sep 2021	2	1	1
Oct 2021	13	0	0
Nov 2021	23	0	0
Dec 2021	27	1	0
Jan 2022	12	0	0
Feb 2022	16	0	0
Mar 2022	23	0	0
Apr 2022	13	0	0
May 2022	40	0	1
Jun 2022	31	0	0
Jul 2022	14	2	0
Aug 2022	58	0	1
Sep 2022	42	0	1
Oct 2022	39	0	0
Nov 2022	18	0	0
Dec 2022	11	1	0
Jan 2023	16	0	0
Feb 2023	30	2	1
Total	2875	258	144